Complete Suite of Glycan Sample Preparation and Analysis Consumables
N-linked glycosylation is a critically important and complex post-translational modification. The structure of N-linked glycans can influence the function of glycosylated biotherapeutics, making the characterization of N-glycans an essential part of the therapeutic development process. Agilent has a complete offering of glycan sample preparation and analysis consumables to support a comprehensive end-to-end N-glycan workflow solution.
Find everything you need, from fast, easy-to-use sample prep kits with a variety of N-glycan labels, to labeled or unlabeled glycan standards, enzymes for structural characterization, to HILIC columns for optimized chromatographic separation of the major glycan species and critical pairs.
Agilent received two 2022 Scientists’ Choice Awards for Drug Discovery & Development, Virtual Event of the Year and Innovative Content of the Year, at the SLAS2022 International Conference & Exhibition on February 7th, 2022. The Scientists’ Choice Awards recognize the world’s most innovative and effective analytical science technologies and communications.
Professor Michael Butler, head of the National Institute for Bioprocessing Research and Training (NIBRT) Cell Technology Group (CTG), explains that the characterisation and analysis of glycans is important for the biopharma sector as it can help in the development of therapeutic agents, such as monoclonal antibodies and other recombinant proteins. These are used in therapies in a range of serious conditions including cancer, inflammatory diseases, and cardiovascular diseases. The mechanism of action depends upon their strong affinity to molecular targets associated with disease.